Galapagos NV - Volume dana dhuwit perusahaan GLPG

Logo grafis Galapagos (GLPG)

Development risks associated with small molecules for inflammation are driving volatility, as evidenced by the current cash position, where the metric stands at 3.53. Galapagos NV (GLPG) is aiming to regain its leadership through a team refresh and a strategic pivot toward cell therapy. Meanwhile, royalties from European sales and high liquidity ensure stability, supporting the overall financial health of the business.

GLPG - Posisi dhuwit perusahaan Galapagos Genomics ing rentang 04.07.2022 - 08.05.2026

Rincian analitis lan laporan data perusahaan Galapagos Genomics (GLPG)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:GLPG Galapagos
Produk mawa merek Galapagos N.V.

This indicator measures the issuer's actual liquidity, excluding non-cash assets and accounting profits to assess the real solvency reserve. By analyzing the cash balance, an investor can determine the burn rate, which is critically important for Galapagos NV (GLPG) when financing costly CAR-T therapy developments and maintaining its strategic partnership with Gilead.

Karo sapa Galapagos NV saingan

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dhuwit awis perusahaan LQDA|Dhuwit awis perusahaan ANI Pharmaceuticals, Inc. (ANIP)|Volume dana dhuwit perusahaan MNKD|AMPH (Amphastar Corp) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan pacira.com PCRX|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan